Cargando…
Parallel Murine and Human Aortic Wall Genomics Reveals Metabolic Reprogramming as Key Driver of Abdominal Aortic Aneurysm Progression
BACKGROUND: While numerous interventions effectively interfered with abdominal aortic aneurysm (AAA) formation/progression in preclinical models, none of the successes translated into clinical success. Hence, a systematic exploration of parallel and divergent processes in clinical AAA disease and it...
Autores principales: | Gäbel, Gabor, Northoff, Bernd H., Balboa, Amanda, Becirovic‐ Agic, Mediha, Petri, Marcelo, Busch, Albert, Maegdefessel, Lars, Mahlmann, Adrian, Ludwig, Stefan, Teupser, Daniel, de Waard, Vivian, Golledge, Jonathan, Wanhainen, Anders, Wågsäter, Dick, Holdt, Lesca M., Lindeman, Jan H. N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649280/ https://www.ncbi.nlm.nih.gov/pubmed/34420357 http://dx.doi.org/10.1161/JAHA.120.020231 |
Ejemplares similares
-
Inhibition of angiotensin-induced aortic aneurysm by metformin in apolipoprotein E–deficient mice
por: Kunath, Anne, et al.
Publicado: (2021) -
Molecular Fingerprint for Terminal Abdominal Aortic Aneurysm Disease
por: Gäbel, Gabor, et al.
Publicado: (2017) -
Differential gene expression in human abdominal aortic aneurysm and aortic occlusive disease
por: Biros, Erik, et al.
Publicado: (2015) -
Cysteinyl leukotriene receptor 1 antagonism prevents experimental abdominal aortic aneurysm
por: Di Gennaro, Antonio, et al.
Publicado: (2018) -
The cardiac wound healing response to myocardial infarction
por: Chalise, Upendra, et al.
Publicado: (2022)